Cancer trial drug may target tumors differently than originally believed
A experimental cancer drug now in human clinical trials may have advanced based on a flawed understanding of its mechanism, a university study found.
FTMQ Health, written by our newsroom0 views

Medical Xpress reported that an experimental cancer drug currently undergoing patient testing may have entered clinical trials based on an incorrect understanding of how it functions. The study raising these concerns was led by the University of Sydney in collaboration with Goethe University, Oxford University, and the Institute of Cancer Research in London. [1]
The finding raises concerns for clinical research practices surrounding drug development. Clinical trials are prospective research studies conducted on human participants to answer specific questions about safety, dosage, and efficacy, according to Wikipedia. Human trials take place only after receiving regulatory ethics approval based on a calculated risk to benefit ratio. [1][2]
Understanding how treatments function is critical as the global impact of the disease expands. Grokipedia notes that an estimated 20 million new cancer cases were diagnosed worldwide in 2022, resulting in 9.7 million deaths, with projections indicating a 77 percent increase in the overall burden by 2050. [3]
Researchers behind the new university study continue to evaluate how the drug operates to ensure clinical trials accurately assess its potential impact on patients. [1]
In short
- A cancer drug in clinical trials may work differently than researchers originally believed.
- The study was led by the University of Sydney alongside researchers from Oxford University.
- Clinical trials generate crucial safety and dosage data on human participants.
Sources
Every paragraph above points to the numbered items it rests on. Read the originals here.
- [1]Cancer trial drug may work differently than scientists believed, raising concerns for clinical researchMedical Xpress, 46d ago (the report this story comes from)
Background
- [2]Clinical trial on Wikipedia
- [3]Cancer on Grokipedia
Our newsroom writes these reports with the help of software, from the 3 sources listed and nothing else, and checks them against those sources. Facts can still be wrong or move on; the originals are the record. Spotted a mistake? Write to daniel@monsterkong.com.
Related from FTMQ Health
Earlier reports of ours on the same people and subjects.
- Merck and Moderna advance personalized mRNA cancer vaccine clinical trialsTop Stories, 36d ago
- UT Southwestern trial tests targeted radiation for advanced kidney cancer complicationMedical Science, 36d ago
- University of Chicago researchers identify mechanism to reverse radiation immune suppressionTop Stories, 20d ago
- Servier muscular dystrophy drug fails trialTop Stories, 17d ago
- Experimental weight loss drug retatrutide reduces knee pain in trialsMedical Science, 12d ago
More in Top Stories
- United Therapeutics performs first UThymoKidney transplant in EXTEND trial16h ago
- Princeton neuroscience researcher detained by ICE following conference16h ago
- FDA rejects Capricor Therapeutics Duchenne muscular dystrophy cell therapy16h ago
- Northern Ireland ambulance service misses two-hour target over 2,000 times1d ago
- Senior surgeon calls for police investigation into Scottish hospital patient deaths1d ago
- Malaria antibody prevents infection in infants but interferes with vaccine1d ago
Get the day in one email
Reports like this one, the top news of the last 24 hours, every morning. Free, one email a day; readers can comment under every report.
By signing up you agree to our terms and privacy policy. Unsubscribe any time.

Comments
Loading
Join the conversation
Comments are open to readers of our daily email: the top news of the last 24 hours, every morning, free. Sign up and the comment box opens.
Already on the list? Enter the same address and we will send a sign-in link.
By signing up you agree to our terms and privacy policy. Unsubscribe any time.